Clinical Trial Update: Sevelamer in Proteinuric CKD [Phase 2]

View source ↗

Summary

Phase 2 trial of sevelamer in proteinuric chronic kidney disease has completed; sponsor is the Mario Negri Institute for Pharmacological Research.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Sevelamer (sevelamer hydrochloride)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED